Contact: Kara Gavin
University of Michigan Health System
Caption: This CT scan shows the "honeycomb" pattern of scarring in the lungs of a patient with idiopathic pulmonary fibrosis, a progressive disease with few good treatment options. A new study has found that a three-drug combination used worldwide to treat IPF is in fact associated with a high risk of death and hospitalization than placebo.
Credit: University of Michigan Health System
Usage Restrictions: None
Related news release: First, do no harm: Study finds danger in standard treatment for a serious lung disease